BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20146242)

  • 1. Adverse drug reactions induced by cardiovascular drugs in cardiovascular care unit patients.
    Mohebbi N; Shalviri G; Salarifar M; Salamzadeh J; Gholami K
    Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):889-94. PubMed ID: 20146242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug reactions in patients with cardiovascular disease.
    Faulx MD; Francis GS
    Curr Probl Cardiol; 2008 Dec; 33(12):703-68. PubMed ID: 19000586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Side effects of cardiovascular drugs].
    Koleva T; Madzharova Iu; Baleva V; Dragoĭcheva Ts; Stoĭkova K
    Vutr Boles; 1989; 28(5):24-30. PubMed ID: 2618006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New cardiovascular-active drugs].
    Bölter C
    Z Arztl Fortbild (Jena); 1984; 78(19):797-800. PubMed ID: 6506791
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse drug reactions (ADRs) in patients with heart diseases. Comparison between patients without and with heart failure.
    Ruiz I; Ortiz M
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):595-601. PubMed ID: 6500756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug reactions resulting in hospital admission.
    Huic M; Mucolic V; Vrhovac B; Francetic I; Bakran I; Giljanovic S
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):675-82. PubMed ID: 7881707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Readmissions and adverse drug reactions in internal medicine: the economic impact.
    Dormann H; Neubert A; Criegee-Rieck M; Egger T; Radespiel-Tröger M; Azaz-Livshits T; Levy M; Brune K; Hahn EG
    J Intern Med; 2004 Jun; 255(6):653-63. PubMed ID: 15147529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions to antiretroviral therapy (ART): an experience of spontaneous reporting and intensive monitoring from ART centre in India.
    Modayil RR; Harugeri A; Parthasarathi G; Ramesh M; Prasad R; Naik V; Giriyapura V
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):247-55. PubMed ID: 20066675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse reactions of anti-tuberculosis drugs in hospitalized patients: incidence, severity and risk factors.
    Javadi MR; Shalviri G; Gholami K; Salamzadeh J; Maghooli G; Mirsaeedi SM
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1104-10. PubMed ID: 17823987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: one-year follow-up of a large prospective cohort.
    Stenestrand U; Wallentin L;
    Arch Intern Med; 2003 Apr; 163(8):965-71. PubMed ID: 12719207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden of modifiable cardiovascular risk factors in the coronary care unit by age, ethnicity, and socioeconomic status--PREDICT CVD-9.
    Kerr AJ; McLachlan A; Furness S; Broad J; Riddell T; Jackson R; Wells S
    N Z Med J; 2008 Nov; 121(1285):20-33. PubMed ID: 19079434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-infectives-induced adverse drug reactions in hospitalized patients.
    Gholami K; Parsa S; Shalviri G; Sharifzadeh M; Assasi N
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):501-6. PubMed ID: 15844215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study.
    De Luca L; Bolognese L; Casella G; Savonitto S; Gonzini L; Di Chiara A; De Servi S; Notaristefano S; Valagussa L; Maggioni AP; Chiarella F;
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1045-51. PubMed ID: 18799968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacologic and therapeutic peculiarities in the aged, especially in the cardiovascular diseases].
    Klaus W
    Z Kardiol; 1985; 74 Suppl 7():27-31. PubMed ID: 2868583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of adverse drug reactions on length of stay in surgical intensive care units.
    Vargas E; Terleira A; Hernando F; Perez E; Cordón C; Moreno A; Portolés A
    Crit Care Med; 2003 Mar; 31(3):694-8. PubMed ID: 12626971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions in hospitalized psychiatric patients.
    Thomas M; Boggs AA; DiPaula B; Siddiqi S
    Ann Pharmacother; 2010 May; 44(5):819-25. PubMed ID: 20371749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular medications.
    Williams S; Wynn G; Cozza K; Sandson NB
    Psychosomatics; 2007; 48(6):537-47. PubMed ID: 18071104
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse cardiovascular drug interactions.
    Opie LH
    Curr Probl Cardiol; 2000 Sep; 25(9):621-76. PubMed ID: 11043147
    [No Abstract]   [Full Text] [Related]  

  • 19. A prospective study of adverse drug reactions in a dermatology department.
    Ganeva M; Gancheva T; Lazarova R; Tzvetanova Y; Hristakieva E
    Methods Find Exp Clin Pharmacol; 2007 Mar; 29(2):107-12. PubMed ID: 17440627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy in advanced age].
    Scholz H
    Med Monatsschr Pharm; 1996 May; 19(5):132-9. PubMed ID: 8684309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.